#USA #Boston #HoneyNaps #SOMNUM™ #AI Sleep Software

HoneyNaps' SOMNUM™ Achieves Prestigious Recognition

In a significant milestone for HoneyNaps, their AI-powered sleep diagnosis software, SOMNUM™, has been honored as a 2025 Next Generation World Class Product. This recognition was awarded during the 2025 World Class Product of Korea Certification Ceremony held at Lotte Hotel World in Seoul on November 18. The ceremony, organized by Korea’s Ministry of Trade, Industry, and Resources (MOTIR) and the Korea Trade-Investment Promotion Agency (KOTRA), highlighted both technological advancements and the promising potential for global market leadership.

A Look into SOMNUM™

SOMNUM™ sets itself apart through its innovative use of deep learning algorithms to automatically score multi-channel polysomnography signals. This marks a departure from traditional image-based AI systems. As the first deep-learning platform of its kind in Korea, SOMNUM™ is designed for large-scale, real-time signal scoring, enhancing the accuracy and efficiency of sleep disorder diagnosis. The platform’s use of eXplainable AI (XAI) further allows medical professionals to understand and trust the AI's scoring rationale, thus bridging the gap between technology and clinical practice.

Validation has come in the form of FDA clearance in the U.S. and a designation as an Innovative Medical Device in Korea, leading to an increasing adoption rate in medical institutions both domestically and internationally. This growth trajectory is supported by the World Class Product initiative, which since its inception in 2001, has aimed to identify and promote products with strong potential for global market leadership.

Government Support and Future Prospects

Certified companies like HoneyNaps benefit from significant government assistance for global marketing, export consulting, and promotional support, fueling their path to establishing a strong presence in international markets. At the recent ceremony, a business consultation event facilitated connections between 100 overseas buyers and 150 participating companies, resulting in 11 export contracts valued at approximately USD 16.3 million.

Dr. Taekyoung (Sean) Ha, President of HoneyNaps USA, expressed pride in the recognition, stating, "This designation as a Next Generation World Class Product reflects the global competitiveness and growth potential of our AI-driven sleep medicine technology. We will continue to strengthen our technological leadership to ensure SOMNUM remains a leading innovation in sleep technology."

As HoneyNaps accelerates its global expansion, it aims to solidify its position as a front-runner in the SleepTech industry. The recognition as a Next Generation World Class Product promises to enhance brand visibility and boost confidence among stakeholders, paving the way for transformative changes in sleep management solutions worldwide.

For further information on SOMNUM™ and the innovative technologies from HoneyNaps, you can reach out to Christine Kwon, Managing Director of HoneyNaps USA, at their Boston headquarters located at #517, SPACES, 361 Newbury Street, Boston, MA, 02115, or visit their website at www.honeynaps.com.